Manipulation of brain CDP-diacylglycerol and uses thereof
OwnerAshiwel S. Undiehinventor
Life of this patent
Estimating the term…
Abstract
Provided herein methods of screening for potential antidepressant compounds effective to increase production of cellular CDP-diacylglycerol and synthesis of inositol phospholipid in depression-related areas of the brain. Also, provided are methods of diagnosing and treating depressive or mood disorders in a subject by administering these screened antidepressant compounds. Further provided is a method of determining the therapeutic efficacy of an antidepressant drug regimen by comparing the ratio of CDP-diacylglycerol/inositol phosphate after treatment to a basal ratio in a subject.
Claims8
A method of diagnosing a depressive disorder in a subject, comprising:
- determining a basal CDP-diacylglycerol/inositol phosphate index that is the ratio of a level of CDP-diacylglycerol to a level of inositolphosphatein the subject;
- and comparing the basal CDP-diacylglycerol/inositol phosphate index to a control CDP-diacylglycerol/inositol phosphate index, wherein a lower basal CDP-diacylglycerol/inositol phosphate index indicates the subject has a depressive disorder, wherein the depressive disorder is major depression, unipolar depression, bipolar depression, reactive depression, endogenous depression, or dysthymic disorder.
Dependencies are inferred from the claim text.